OCA2 and peeling skin syndrome: Hsu et al. proposed anti-β2-glycoprotein-I (aβ2GP-I) and perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) levels as risks for the appearance of neuropathy in patients with pSS [20].